Decoy Therapeutics Inc. Non Peo Neo Avg Total Comp Amt
Decoy Therapeutics Inc. (DCOY) reported Non Peo Neo Avg Total Comp Amt of $225.06 thousand for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-06-04.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-06-04
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $225.06K DEF 14A · filed 2026-06-04 |
| 2024-12-31 | $350.42K DEF 14A · filed 2026-06-04 |
| 2023-12-31 | $355.76K DEF 14A · filed 2026-06-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |